DNS-7801 vs. Placebo in Parkinson's Disease

Summary

This is a randomized, double-blind, two-part placebo-controlled parallel group outpatient treatment study that will utilize standard Parkinson's Disease measures to evaluate the effect of DNS-7801

Timeline

Start

2017-09-13

Primary completion

2017-12-31

Completion

2017-12-31

Outcome

Outcome not reported

Stopped: “Administrative”

Drugs

Indications